Company intelligence / Profile preview

SteadyMed Therapeutics

San Ramon, CA, United Statesfinder.startupnationcentral.org ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

SteadyMed developed the PatchPump®, a customizable, prefilled, pre-programmed disposable wearable injector designed to deliver large-volume and viscous drugs with precise electronic control. The company advanced its own therapeutic portfolio and partnered with others to optimize parenteral drug delivery. It was acquired by United Therapeutics in August 2018 for its technology and pipeline.

Therapeutic areas: OtherCardiovascular
Modalities: Device (Wearable injector)Small molecule (as delivery target)Biologic (as delivery target)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

treprostinil

Commercial

Indications: Pulmonary arterial hypertension

Partnerships

Partnered with pharmaceutical companies seeking advanced parenteral drug delivery solutions using PatchPump platform.

Beyond the preview

Go deeper on SteadyMed Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SteadyMed Therapeutics.

Explore the full profile